<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2019.00111</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Human Macrophages Clear the Biovar Microtus Strain of <italic>Yersinia pestis</italic> More Efficiently Than Murine Macrophages</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Qingwen</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Xin</surname> <given-names>Youquan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x02020;</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhao</surname> <given-names>Haihong</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Liu</surname> <given-names>Rongjiao</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Xu</surname> <given-names>Xiaoqing</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Yan</surname> <given-names>Yanfeng</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/210395/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Kong</surname> <given-names>Zhipeng</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Tong</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Qi</surname> <given-names>Zhizhen</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhang</surname> <given-names>Qi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>You</surname> <given-names>Yang</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Song</surname> <given-names>Yajun</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/23573/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Cui</surname> <given-names>Yujun</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Yang</surname> <given-names>Ruifu</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c002"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/15993/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhang</surname> <given-names>Xuefei</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c003"><sup>&#x0002A;</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Du</surname> <given-names>Zongmin</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/337566/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Qinghai Institute for Endemic Disease Prevention and Control</institution>, <addr-line>Xining</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology</institution>, <addr-line>Beijing</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Hasan Zaki, University of Texas Southwestern Medical Center, United States</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Roger Derek Pechous, University of Arkansas for Medical Sciences, United States; Yuan He, Wayne State School of Medicine, United States</p></fn>
<corresp id="c001">&#x0002A;Correspondence: Zongmin Du <email>zmduams&#x00040;163.com</email></corresp>
<corresp id="c002">Ruifu Yang <email>ruifuyang&#x00040;gmail.com</email></corresp>
<corresp id="c003">Xuefei Zhang <email>1730326847&#x00040;qq.com</email></corresp>
<fn fn-type="other" id="fn001"><p>This article was submitted to Microbes and Innate Immunity, a section of the journal Frontiers in Cellular and Infection Microbiology</p></fn>
<fn fn-type="other" id="fn002"><p>&#x02020;These authors have contributed equally to this work</p></fn></author-notes>
<pub-date pub-type="epub">
<day>24</day>
<month>04</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>9</volume>
<elocation-id>111</elocation-id>
<history>
<date date-type="received">
<day>10</day>
<month>01</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>29</day>
<month>03</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2019 Zhang, Xin, Zhao, Liu, Xu, Yan, Kong, Wang, Qi, Zhang, You, Song, Cui, Yang, Zhang and Du.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Zhang, Xin, Zhao, Liu, Xu, Yan, Kong, Wang, Qi, Zhang, You, Song, Cui, Yang, Zhang and Du</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract><p><italic>Yersinia pestis</italic> is the etiological agent of the notorious plague that has claimed millions of deaths in history. Of the four known <italic>Y. pestis</italic> biovars (Antiqua, Medievalis, Orientalis, and Microtus), Microtus strains are unique for being highly virulent in mice but avirulent in humans. Here, human peripheral lymphocytes were infected with the fully virulent 141 strain or the Microtus strain 201, and their transcriptomes were determined and compared. The most notable finding was that robust responses in the pathways for cytokine-cytokine receptor interaction, chemokine signaling pathway, Toll-like receptor signaling and Jak-STAT signaling were induced at 2 h post infection (hpi) in the 201- but not the 141-infected lymphocytes, suggesting that human lymphocytes might be able to constrain infections caused by strain 201 but not 141. Consistent with the transcriptome results, much higher IFN-&#x003B3; and IL-1&#x003B2; were present in the supernatants from the 201-infected lymphocytes, while inflammatory inhibitory IL-10 levels were higher in the 141-infected lymphocytes. The expressions of CSTD and SLC11A1, both of which are functional components of the lysosome, increased in the 201-infected human macrophage-like U937 cells. Further assessment of the survival rate of the 201 bacilli in the U937 cells and murine macrophage RAW 264.7 cells revealed no viable bacteria in the U937 cells at 32 hpi.; however, about 5&#x02013;10% of the bacteria were still alive in the RAW264.7 cells. Our results indicate that human macrophages can clear the intracellular <italic>Y. pestis</italic> 201 bacilli more efficiently than murine macrophages, probably by interfering with critical host immune responses, and this could partially account for the host-specific pathogenicity of <italic>Y. pestis</italic> Microtus strains.</p></abstract>
<kwd-group>
<kwd><italic>Yersinia pestis</italic></kwd>
<kwd>host-specific pathogenicity</kwd>
<kwd>biovar microtus</kwd>
<kwd>human lymphocyte</kwd>
<kwd>transcriptomes</kwd>
</kwd-group>
<counts>
<fig-count count="5"/>
<table-count count="2"/>
<equation-count count="0"/>
<ref-count count="44"/>
<page-count count="11"/>
<word-count count="7792"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introductions</title>
<p><italic>Yersina pestis</italic>, the causative agent of plague, is responsible for three historical pandemics including the notorious Black Death in medieval Europe (Perry and Fetherston, <xref ref-type="bibr" rid="B30">1997</xref>; Butler, <xref ref-type="bibr" rid="B4">2009</xref>). This lethal pathogen manifests itself as three main clinical forms: bubonic plague, pneumonic plague and septicemia plague (Perry and Fetherston, <xref ref-type="bibr" rid="B30">1997</xref>). Pneumonic plague, the most serious form of the disease, leads to the certain death of victims if not properly treated in time. <italic>Y. pestis</italic> is a highly contagious pathogen that can spread quickly among closely contacted individuals by airborne droplets, thereby posing the potential threat of disease outbreaks in populations under suitable circumstances, which could include bioterrorism (Inglesby et al., <xref ref-type="bibr" rid="B16">2000</xref>). Different <italic>Y. pestis</italic> strains are classified into four biovars (Antiqua, Mediaevalis, Orientalis and Microtus) according to their phenotypic properties (Zhou et al., <xref ref-type="bibr" rid="B43">2004</xref>). Since the announcement of whole genome sequences of <italic>Y. pestis</italic> CO92 (biovar Orientalis) and KIM (biovars Mediaevalis) (Parkhill et al., <xref ref-type="bibr" rid="B29">2001</xref>; Deng et al., <xref ref-type="bibr" rid="B9">2002</xref>), the whole genome sequence data for more than 30 different <italic>Y. pestis</italic> strains, including each of the four biovars, have been released so far (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">https://www.ncbi.nlm.nih.gov/</ext-link>). Biovar Microtus was recently proposed to be a novel <italic>Y. pestis</italic> biovar because strains isolated from Microtus-related plague foci in China are lethal to microtus and other small rodents but avirulent to larger mammals and human (Fan et al., <xref ref-type="bibr" rid="B11">1995</xref>), and unlike strains belonging to the three classical biovars, those strains can reduce nitrate, ferment rhamnose and melibiose, but not arabinose (Zhou et al., <xref ref-type="bibr" rid="B43">2004</xref>). Biovar Microtus strains are distributed in the <italic>Microtus brandti</italic> plague focus of the Xilin Gol Grassland and the <italic>M. fuscus</italic> plague focus of the Qinghai-Tibet Plateau in China. However, since the first isolation of <italic>Y. pestis</italic> strains in the 1970s from the Microtus-related foci in China, no cases of human plague have been reported to be linked to these strains although serious enzootic plague epidemics have occurred every few years in the same areas. Human volunteers were subcutaneously inoculated with 1.5 &#x000D7; 10<sup>7</sup> colony forming units (CFU) of the <italic>Y. pestis</italic> strains isolated from Microtus-related foci and the results confirmed for the first time that these strains are avirulent in humans (Fan et al., <xref ref-type="bibr" rid="B11">1995</xref>).</p>
<p>It has been established that <italic>Y. pestis</italic> has evolved recently from <italic>Y. pseudotuberculosis</italic> and only limited genetic diversity has been found among the different <italic>Y. pestis</italic> strains (Achtman et al., <xref ref-type="bibr" rid="B2">1999</xref>, <xref ref-type="bibr" rid="B1">2004</xref>). The genome composition of the different <italic>Y. pestis</italic> biovars are very similar, although there is evidence of frequent events of gene rearrangement, large gene fragments deletion, gene loss, and gene inactivation among those genomes (Song et al., <xref ref-type="bibr" rid="B38">2004</xref>). However, despite the monumental advances in comparative genomics and proteomics that have taken place over recent years, we are no further in elucidating the mechanisms underlying the host-specific pathogenicity of the Microtus strains (Song et al., <xref ref-type="bibr" rid="B38">2004</xref>; Zhou et al., <xref ref-type="bibr" rid="B44">2012</xref>). Therefore, in the present study, human peripheral lymphocytes were infected with the fully virulent biovar Antiqua strain 141 or the human avirulent Microtus strain 201, and their transcriptomes were compared. We observed significantly different responses in, for example, the cytokine-cytokine receptor interaction pathway, chemokine signaling pathway, Toll-like receptor (TLR) signaling pathway, and lysosome pathways between the 201- and 141- infected lymphocytes, suggesting that the ability of human lymphocytes to restrict infection caused by strain 201 or 141 might be very different. IFN-&#x003B3; and IL-1&#x003B2;, which are recognized to benefit the host defenses against plague, were present at significantly higher levels in the supernatant from the 201-infected lymphocytes, while levels of the inhibitory IL-10 inflammatory cytokines were higher in 141-infected lymphocytes. Further assessment of the survival of 201 bacilli in human macrophage-like U937 cells and murine macrophage RAW 264.7 cells revealed that human macrophages clear intracellular <italic>Y. pestis</italic> 201 bacilli more efficiently than mice macrophages do. Our results showed that human macrophages exhibit much higher bactericidal activities than mouse macrophages and this finding might partially account for the host-specific pathogenicity of <italic>Y. pestis</italic> Microtus strains.</p>
</sec>
<sec sec-type="results" id="s2">
<title>Results</title>
<sec>
<title>Overview of the Comparative Transcriptome of Human Peripheral Lymphocytes Infected With Different <italic>Y. pestis</italic> Biovars Strains</title>
<p>Human peripheral lymphocytes were infected with the human-avirulent Microtus 201 strain or the fully virulent Antiqua strain 141 each at a multiplicity of infection (MOI) of 10. The infected lymphocytes harvested at 2, 4, and 8 h post-infection (hpi) were subjected to the total RNA isolation and RNA sequencing (RNA-seq) analysis. Clean reads from the RNA-seq analysis were mapped to the annotated human genome (NCBI36/hg18). Each library comprised around 4.5 &#x000D7; 10<sup>7</sup> clean reads, 62.83% of which were on average mapped uniquely to the human reference genome (<xref ref-type="table" rid="T1">Table 1</xref>). Gene expression was calculated using the fragments per kilobase of gene per million fragments mapped (FPKM) method (Mortazavi et al., <xref ref-type="bibr" rid="B27">2008</xref>), and the genes whose expression levels were altered by over 2-fold in expression level with false discovery rates (FDRs) &#x02264; 0.001 were defined as being the differentially expressed genes (Benjamini and Yekutieli, <xref ref-type="bibr" rid="B3">2005</xref>).</p>
<table-wrap position="float" id="T1">
<label>Table 1</label>
<caption><p>RNA-seq library descriptions.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>ID</bold></th>
<th valign="top" align="center"><bold>Sample name</bold></th>
<th valign="top" align="center"><bold>Clean reads<xref ref-type="table-fn" rid="TN1"><sup>a</sup></xref></bold></th>
<th valign="top" align="center"><bold>Unique match (percent)<xref ref-type="table-fn" rid="TN2"><sup>b</sup></xref></bold></th>
<th valign="top" align="center"><bold>Total unmapped reads (percent)<xref ref-type="table-fn" rid="TN3"><sup>c</sup></xref></bold></th>
<th valign="top" align="center"><bold>Expressed gene</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">1</td>
<td valign="top" align="center">141-2h</td>
<td valign="top" align="center">44641336</td>
<td valign="top" align="center">29202733 (65.42%)</td>
<td valign="top" align="center">13240983 (29.69%)</td>
<td valign="top" align="center">15462</td>
</tr>
<tr>
<td valign="top" align="left">2</td>
<td valign="top" align="center">141-4h</td>
<td valign="top" align="center">45138004</td>
<td valign="top" align="center">29179029 (64.64%)</td>
<td valign="top" align="center">13934344 (30.87%)</td>
<td valign="top" align="center">15477</td>
</tr>
<tr>
<td valign="top" align="left">3</td>
<td valign="top" align="center">141-8h</td>
<td valign="top" align="center">44789942</td>
<td valign="top" align="center">28803453 (64.31%)</td>
<td valign="top" align="center">14196597 (31.70%)</td>
<td valign="top" align="center">15568</td>
</tr>
<tr>
<td valign="top" align="left">4</td>
<td valign="top" align="center">201-2h</td>
<td valign="top" align="center">44201980</td>
<td valign="top" align="center">28907751 (65.40%)</td>
<td valign="top" align="center">13441594 (30.41%)</td>
<td valign="top" align="center">15547</td>
</tr>
<tr>
<td valign="top" align="left">5</td>
<td valign="top" align="center">201-4h</td>
<td valign="top" align="center">44294928</td>
<td valign="top" align="center">27656449 (62.44%)</td>
<td valign="top" align="center">13662809 (30.85%)</td>
<td valign="top" align="center">15506</td>
</tr>
<tr>
<td valign="top" align="left">6</td>
<td valign="top" align="center">201-8h</td>
<td valign="top" align="center">44851572</td>
<td valign="top" align="center">27616280 (61.57%)</td>
<td valign="top" align="center">14148314 (31.54%)</td>
<td valign="top" align="center">15570</td>
</tr>
<tr>
<td valign="top" align="left">7</td>
<td valign="top" align="center">Normal</td>
<td valign="top" align="center">44701980</td>
<td valign="top" align="center">28449706 (63.64%)</td>
<td valign="top" align="center">13266250 (29.68%)</td>
<td valign="top" align="center">15512</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="TN1">
<label>a</label>
<p><italic>Clean reads represent the number of high quality clean reads.</italic></p></fn>
<fn id="TN2">
<label>b</label>
<p><italic>Unique matches denotes the reads that mapped to unique positions in the reference human genome.</italic></p></fn>
<fn id="TN3">
<label>c</label>
<p><italic>Total unmapped reads denotes the number of reads that couldn&#x00027;t be mapped to the reference genome.</italic></p></fn>
<p><italic>The percentages of the unique matched reads and the unmapped reads were calculated by dividing the values of the unique or unmapped reads by those of the clean reads of clean reads &#x000D7; 100 (values shown in brackets)</italic>.</p>
</table-wrap-foot>
</table-wrap>
<p>First, the transcriptomes of the peripheral lymphocytes infected with strains 201 or 141 were compared with that of the uninfected lymphocytes, respectively. Differentially expressed genes were identified according to the aforementioned criteria and the numbers of genes at each time point post-infection were calculated. More than 260 genes were differentially expressed at 2 hpi between the 201-infected and uninfected lymphocytes, and the number increased greatly as the infection period proceeded and exceeded 1,600 at 8 hpi (<xref ref-type="fig" rid="F1">Figure 1A</xref>). In sharp contrast, the transcriptome of the 141-infected peripheral lymphocytes differed very little from that of the uninfected cells at 2 hpi, and fewer than 20 genes were found to be differentially expressed, although the numbers of differentially expressed genes at 8 hpi in the 141- and 201-infected cells were high and comparable (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Differentially expressed genes in human peripheral lymphocytes infected with <italic>Y. pestis</italic> 201 or 141 strains. Numbers of genes that were differentially expressed at 2, 4, and 8 hpi in 201-infected <bold>(A)</bold> or 141-infected lymphocytes <bold>(B)</bold> in comparison with the uninfected lymphocytes and between the 201-infected and 141-infected lymphocytes <bold>(C)</bold> are shown here.</p></caption>
<graphic xlink:href="fcimb-09-00111-g0001.tif"/>
</fig>
<p>Further comparative analysis showed once again that the most remarkable gene expression changes between the 201- and 141-infected peripheral lymphocytes occurred at the earliest time point that was analyzed (<xref ref-type="fig" rid="F1">Figure 1C</xref>). The differentially expressed genes were relatively fewer at 8 hpi although they were quite abundant in the 201-infected (<xref ref-type="fig" rid="F1">Figure 1A</xref>) and the 141-infected (<xref ref-type="fig" rid="F1">Figure 1B</xref>) lymphocytes in comparison with the uninfected lymphocytes control. These data demonstrate that the initial contact by the human peripheral lymphocytes with the two <italic>Y. pestis</italic> strains triggered two obviously distinct responses, one of which could possibly facilitate efficient recognition of 201 bacilli and boost strong immune responses, while the other failed to do so in the case of infection with <italic>Y. pestis</italic> strain 141. It appeared that the 141-infected lymphocytes were strongly inhibited in their ability to deploy an inflammatory immune response because of a vital virulence mechanism present in strain 141, but absent in strain 201, which might originate from some as yet uncharacterized difference(s) between the two strains.</p>
<p>To validate the RNA-seq data, primer pairs for 23 genes were designed for quantitative RT-PCR analysis (<xref ref-type="supplementary-material" rid="SM4">Supplementary Table 1</xref>), among which 12 genes were up-regulated, 7 genes down-regulated and 3 unchanged in the 201-infected lymphocytes in comparison with the uninfected control according to the RNA-seq results. qRT-PCR was performed using the same RNA samples used in RNA-seq library construction as templates, 16s RNA was the reference gene for data normalization, and the log2 ratios of the target gene concentrations in the 201-infected lymphocytes to those of the uninfected control were calculated. The correlation efficiencies (R<sup>2</sup>) between the qRT-PCR and RNA-seq analysis results were over 0.90 for the RNA samples collected at 2 and 8 hpi, and 0.83 for the samples collected at 4 hpi (<xref ref-type="supplementary-material" rid="SM1">Supplementary Figure 1</xref> and <xref ref-type="table" rid="T2">Table 2</xref>). These results indicate that the RNA-seq data described in this study are highly reliable.</p>
<table-wrap position="float" id="T2">
<label>Table 2</label>
<caption><p>Pathway enrichment analysis of the differentially expressed genes in 201- or 141-infeced peripheral lymphocytes.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left"><bold>Pathway term</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>201-infected</bold></th>
<th valign="top" align="center" colspan="3" style="border-bottom: thin solid #000000;"><bold>141-infected</bold></th>
</tr>
<tr>
<th/>
<th valign="top" align="center"><bold>2h</bold></th>
<th valign="top" align="center"><bold>4h</bold></th>
<th valign="top" align="center"><bold>8h</bold></th>
<th valign="top" align="center"><bold>2h</bold></th>
<th valign="top" align="center"><bold>4h</bold></th>
<th valign="top" align="center"><bold>8h</bold></th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">hsa04060:Cytokine-cytokine receptor interaction</td>
<td valign="top" align="center">37</td>
<td valign="top" align="center">29</td>
<td valign="top" align="center">70</td>
<td/>
<td valign="top" align="center">34</td>
<td valign="top" align="center">76</td>
</tr>
<tr>
<td valign="top" align="left">hsa04620:Toll-like receptor signaling pathway</td>
<td valign="top" align="center">13</td>
<td/>
<td/>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">hsa04062:Chemokine signaling pathway</td>
<td valign="top" align="center">16</td>
<td/>
<td valign="top" align="center">40</td>
<td/>
<td valign="top" align="center">16</td>
<td valign="top" align="center">45</td>
</tr>
<tr>
<td valign="top" align="left">hsa04630:Jak-STAT signaling pathway</td>
<td valign="top" align="center">12</td>
<td valign="top" align="center">16</td>
<td/>
<td/>
<td valign="top" align="center">19</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">hsa04640:Hematopoietic cell lineage</td>
<td valign="top" align="center">9</td>
<td/>
<td valign="top" align="center">28</td>
<td/>
<td/>
<td valign="top" align="center">28</td>
</tr>
<tr>
<td valign="top" align="left">hsa04142:Lysosome</td>
<td/>
<td/>
<td valign="top" align="center">30</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">hsa04666:Fc gamma R-mediated phagocytosis</td>
<td/>
<td/>
<td/>
<td/>
<td valign="top" align="center">11</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">hsa04512:ECM-receptor interaction</td>
<td/>
<td/>
<td valign="top" align="center">22</td>
<td/>
<td valign="top" align="center">10</td>
<td/>
</tr>
<tr>
<td valign="top" align="left">hsa04621:NOD-like receptor signaling pathway</td>
<td/>
<td/>
<td valign="top" align="center">18</td>
<td/>
<td/>
<td valign="top" align="center">21</td>
</tr>
<tr>
<td valign="top" align="left">hsa04672:Intestinal immune network for IgA production</td>
<td/>
<td/>
<td valign="top" align="center">15</td>
<td/>
<td/>
<td valign="top" align="center">16</td>
</tr>
<tr>
<td valign="top" align="left">hsa05330:Allograft rejection</td>
<td/>
<td/>
<td valign="top" align="center">12</td>
<td/>
<td/>
<td/>
</tr>
<tr>
<td valign="top" align="left">hsa05310:Asthma</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td valign="top" align="center">13</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<p><italic>Pathway enrichment analysis was performed using DAVID 6.7 bioinformatics tool (<ext-link ext-link-type="uri" xlink:href="http://david.abcc.ncifcrf.gov">http://david.abcc.ncifcrf.gov</ext-link>) (Huang da et al., <xref ref-type="bibr" rid="B15">2009</xref>). Only pathways that were significantly (p &#x0003C; 0.05, Fisher&#x00027;s exact test followed by the Bonferroni multiple testing correction) enriched at any time points in the 201- or 141- infected lymphocytes are shown here. Numbers in the table represents the differentially expressed gene numbers in a specific pathway at the indicated time point</italic>.</p>
</table-wrap-foot>
</table-wrap>
</sec>
<sec>
<title>Multiple Immune Response Pathways Differ in Their Responses to Infection With Strains 201 or 141</title>
<p>To characterize the host transcriptomic response to the human avirulent Microtus strain 201, genes differentially expressed in 201- or 141-infected human peripheral lymphocytes, compared with the uninfected cells, were subjected to the pathway enrichment analysis using the DAVID 6.7 bioinformatics tool (<ext-link ext-link-type="uri" xlink:href="http://david.abcc.ncifcrf.gov">http://david.abcc.ncifcrf.gov</ext-link>) (Huang da et al., <xref ref-type="bibr" rid="B15">2009</xref>). Consistent with the observation that the genes differentially expressed between 201- and 141-infected lymphocytes peaked at 2 hpi, several pathways critical for inducing the intense immune responses required for invading pathogen clearance were significantly enriched in the 201- but not the 141-infected lymphocytes (<italic>p</italic> &#x0003C; 0.05, Fisher&#x00027;s exact test followed by the Bonferroni multiple testing correction) at this time point. These pathways included the cytokine-cytokine receptor interaction pathway, the chemokine signaling pathway, the TLR signaling pathway, and the Jak-STAT signaling pathway, among others (<xref ref-type="table" rid="T2">Table 2</xref>). <xref ref-type="fig" rid="F2">Figure 2</xref> shows the heat maps for some of the differentially enriched pathway in details. Strikingly, at the later infection time points (4 and 8 hpi), the pathway enrichment analysis revealed a significant difference between the 201- and 141-infected lymphocytes in the lysosome pathway, the Fc&#x003B3; receptor-mediated phagocytosis pathway and the extracellular-matrix (ECM) receptor pathway, suggesting that the phagocytosis and lysosome maturation process could be differentially modulated in the lymphocytes infected with the two different strains.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Gene expression patterns of the pathways that showing the significant differences between the <italic>Y. pestis</italic> 201- and 141-infected human peripheral lymphocytes. Some of the critical cellular pathways that were significantly enriched in the genes differentially expressed at 2, 4, or 8 hpi in 201- and 141-infected lymphocytes are shown (<italic>p</italic> &#x0003C; 0.05, Fisher&#x00027;s exact test followed by the Benjamini multiple testing correction). Changes of the differentially expressed genes are presented in different colors as shown in the color key.</p></caption>
<graphic xlink:href="fcimb-09-00111-g0002.tif"/>
</fig>
<p>Pathogens invading the mammalian host are recognized by pathogen recognition receptors (PRRs) via sensing of the conserved ligands on microorganisms (Takeuchi and Akira, <xref ref-type="bibr" rid="B39">2010</xref>), and TLRs represent the major PRRs responsible for bacterial pathogen recognition (Krishnan et al., <xref ref-type="bibr" rid="B20">2007</xref>). The signaling pathways triggered by TLRs exhibit distinct characteristics in several key molecules (<xref ref-type="supplementary-material" rid="SM2">Supplementary Figure 2A</xref>). CD14 protein binds to lipopolysaccharide (LPS), which after transfer to the TLR4/MD-2 complex triggers the downstream signaling required for the production of pro-inflammatory cytokines and type I interferon (Leeuwenberg et al., <xref ref-type="bibr" rid="B22">1994</xref>; Ishihara et al., <xref ref-type="bibr" rid="B17">2004</xref>). TLR adaptor molecule 2 (TICAM2) is an adaptor that transduces signals upon ligand binding to TLR4. Interferon regulatory factor 5 (IRF5) is a transcriptional factor involved in activation of interferon and the immune system. TLR8 recognizes single-stranded RNA from both viruses and bacteria (Sarvestani et al., <xref ref-type="bibr" rid="B36">2012</xref>). The expression levels of <italic>CD14, TLR8, TICAM2</italic>, and <italic>IRF5</italic> were much higher in the 201-infected lymphocytes than in their 141-infected counterparts at 2 hpi, a finding further confirmed by the qRT-PCR analysis (<xref ref-type="supplementary-material" rid="SM2">Supplementary Figure 2B</xref>), although their expression levels after this time point gradually became comparable in the 201- and 141-infected lymphocytes.</p>
<p>As a facultative intracellular pathogen, <italic>Y. pestis</italic> is readily taken up by phagocytes but the pathogen becomes phagocytosis-resistant shortly after its initial intracellular survival and replication (Pujol et al., <xref ref-type="bibr" rid="B33">2009</xref>; Connor et al., <xref ref-type="bibr" rid="B6">2015</xref>). Thus, in systemic infection of the mammalian hosts, the survival of <italic>Y. pestis</italic> in host macrophages at the early stage of infection are critical for the later disease progress. Our results revealed that the differentially expressed genes were significantly enriched in the lysosome pathway in 201-infected lymphocytes, and 30 genes were significantly changed at 8 hpi (<xref ref-type="table" rid="T2">Table 2</xref>) but not in the 141-infected cells. Although we saw no significant enrichment in this pathway at 2 hpi, several key genes (e.g., <italic>ATP6V0A1, CYSZ, CTSD</italic> and <italic>SLC11A1</italic>) involved in lysosome formation and maturation were expressed at higher levels in the 201-infected lymphocytes at 2 hpi than in the 141-infected cells. <italic>ATP6V0A1</italic> encodes a vacuolar ATPase that mediates acidification of intracellular organelles, and vacuolar acidification is necessary for zymogen activation in the lysosome (Saw et al., <xref ref-type="bibr" rid="B37">2011</xref>). CTSD protein exhibits pepsin-like activity, whereas CTSZ is a lysosome cysteine protease that has been shown to have lysosomal degradative capacity (del Cerro-Vadillo et al., <xref ref-type="bibr" rid="B8">2006</xref>; Liu et al., <xref ref-type="bibr" rid="B24">2014</xref>; Tranchemontagne et al., <xref ref-type="bibr" rid="B40">2016</xref>). SLC11A1 functions as a divalent transition metal transporter involved in host resistance to infection with <italic>Mycobacterium tuberculosis</italic> and <italic>M. leprae</italic>, and also is associated with some inflammatory diseases (Govoni et al., <xref ref-type="bibr" rid="B12">1999</xref>). qRT-PCR analysis of the aforementioned genes expressed in the 201- and 141-infected lymphocytes (<xref ref-type="supplementary-material" rid="SM3">Supplementary Figure 3</xref>) confirmed the RNA-seq results that the genes were expressed at higher levels in the 201-infected lymphocytes than in their 141-infected counterparts, suggesting that the lysosome pathway response differed between the infection with strains 201 and 141.</p>
</sec>
<sec>
<title>Cytokine Secretion in Human Lymphocytes Infected With <italic>Y. pestis</italic> Strain 201 Differ Significantly From Those Infected With Strain 141</title>
<p>Next, we sought to compare cytokines and chemokines secretion in lymphocytes infected with the two different strains. Culture supernatants from the infected lymphocytes were collected and analyzed for IL-8, IL-1&#x003B2;, IL-6, IL-10, TNF-&#x003B1;, IL-12p, Interferon-&#x003B3; (IFN-&#x003B3;), IL-17A using BD<sup>TM</sup> CBA Kits. Only the cytokines and chemokines that showed statistically significant differences (<italic>p</italic> &#x0003C; 0.05) were taken into account in the following analysis (<xref ref-type="fig" rid="F3">Figure 3</xref>). The immunological measurements results showed that the 201-infected lymphocytes secreted much more IFN-&#x003B3; and IL-1&#x003B2; than those infected with strain 141. IFN-&#x003B3; is critical for protection against plague and treatment with IFN-&#x003B3; greatly enhances the bactericidal activity of macrophages against the <italic>Y. pestis</italic> bacterium (Pujol et al., <xref ref-type="bibr" rid="B32">2005</xref>; Parent et al., <xref ref-type="bibr" rid="B28">2006</xref>). <italic>Y. pestis</italic> is known to be able to suppress the production of inflammatory cytokines IL-1&#x003B2; to promote its infection process (Ratner et al., <xref ref-type="bibr" rid="B34">2016</xref>). Production of IFN-&#x003B3; and IL-1&#x003B2;, both of which paly essential roles in host immune responses, appear to be significantly inhibited in the presence of strain 141 in comparison with the human avirulent strain 201. By contrast, secretion of the immunosuppressive cytokine Interleukin-10 (IL-10) was significantly higher in the 141-infected lymphocytes, unlike their 201-infected counterparts, which accords with previous reports that IL-10-deficient mice are resistant to <italic>Y. pestis</italic> (Turner et al., <xref ref-type="bibr" rid="B41">2009</xref>).</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Human peripheral lymphocytes infected with the <italic>Y. pestis</italic> 201 strain secreted more abundant IFN-&#x003B3; and IL-1&#x003B2;, and less immunosuppressive IL-10 than those infected with the 141 strain. Culture supernatants from the infected lymphocytes were collected at 2, 4, and 8 hpi and analyzed for the different cytokines using BD<sup>TM</sup> CBA Kits. Significantly higher IFN-&#x003B3; and IL-1&#x003B2; levels were present in the supernatant from the 201-infected lymphocytes, while inflammatory inhibitory IL-10 was higher in the 141-infected lymphocytes at 8 hpi. Figures were drawn using Graphpad Prism 5.0, and the statistical significance of the differences in the cytokine levels between the different groups of samples were analyzed by two-way ANOVA analysis followed by Bonferroni post-tests.</p></caption>
<graphic xlink:href="fcimb-09-00111-g0003.tif"/>
</fig>
</sec>
<sec>
<title>Expression Analysis for Three Essential Proteins in Functional Lysosome in U937 and RAW264.7 Cells Infected With the 201 Strain</title>
<p>The immediate up-regulation of the proteins involved in lysosome activation in 201-infected human lymphocytes promoted us to determine their expression levels after infection with <italic>Y. pestis</italic> strain 201. Human macrophage-like U937 cells primed with phorbol myristate acetate (PMA) and murine macrophage RAW264.7 cells were infected with <italic>Y. pestis</italic> strain 201, and the infected cells collected at 2, 4, 8 hpi were lysed for the immunoblotting detection of ATP6V0A1, SLC11A1, CTSD and CTSZ. Primed U937 cells possess major macrophage characteristics and can therefore resemble lysosome activation quite well in the infected host phagocytes (Koren et al., <xref ref-type="bibr" rid="B19">1979</xref>; Grabenstein et al., <xref ref-type="bibr" rid="B13">2006</xref>). With the exception of ATP6V0A1, whose lack of detection was probably related to its low abundance, all of the other three proteins were successfully detected (<xref ref-type="fig" rid="F4">Figure 4</xref>). The levels of CTSD seemed to be slightly increased in the U937 cells after infection with the 201 strain, and the levels of CTSZ showed no significant alterations during the infection. Because experiments involving human virulent <italic>Y. pestis</italic> strains must be performed at biosafety level 3 laboratory, we were unable to obtain the expression levels of these proteins in 141-infected lymphocytes. However, interestingly, when the RAW264.7 cells were infected with <italic>Y. pestis</italic> strain 201, both the basal expression of CTSD and those after infection were quite low compared with that of the U937 cells, indicating that very low expression of this protease occurred under these conditions. The expression levels of SLC11A1 in both U937 and RAW264.7 cells were significantly increased after infection, and the induction of SLC11A1 in RAW264.7 seemed to be even stronger. The different expression patterns of CTSD and SLC11A1 in U937 and RAW264.7 hinted us that the lysosome activity toward <italic>Y. pestis</italic> strain 201 could be distinctive, which is likely relevant to the host-specific pathogenicity of Microtus strains of <italic>Y. pestis</italic>. However, no significant alteration in CTSZ expression was seen in both U937 and RAW264.7 cells although its&#x00027; transcript level showed &#x0003E; 10-fold abundance at 8 hpi in the human lymphocytes, probably related to some post-transcriptional regulatory mechanisms.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Immunoblotting detection of several proteins involved in lysosome activation in U937 and RAW264.7 cells infected with the <italic>Y. pestis</italic> 201 strain. Human macrophage-like U937 cells primed with PMA and murine macrophage RAW264.7 cells were infected with <italic>Y. pestis</italic> strain 201, and the cells were collected at 2, 4, 8 hpi and lysed for the immunoblotting detection of SLC11A1, CTSD, and CTSZ using specific antibodies. At least three independent experiments were performed and a representative result was shown here. The arrow indicates the position of CTSD bands.</p></caption>
<graphic xlink:href="fcimb-09-00111-g0004.tif"/>
</fig>
</sec>
<sec>
<title>The Survival Rate of <italic>Y. pestis</italic> Strain 201 Is Significantly Lower in U937 Cells Than in RAW264.7 Cells</title>
<p>Because U937 and RAW264.7 cells seemed to respond to 201 and 141 strains differentially in respect of lysosome activation, we wanted to further characterize the interactions of <italic>Y. pestis</italic> strain 201 with these cell lines. U937 and RAW264.7 cells were infected with the bacteria and their survival percentages were measured using a gentamycin protection assay followed by plating cell lysates on agar plates. The U937 cells were stimulated with PMA (100 ng/mL) for 48 h before they were infected. Both U937 and RAW264.7 cells were infected with the <italic>Y. pestis</italic> 201 strain at a MOI of 1 or 5, and the infections were allowed to proceed for 32 h. The number of live bacteria in U937 and RAW264.7 cells at 0.5 h hpi were designated as the initial value and the survival percent at 2, 4, 8, 20, and 32 hpi were calculated by dividing the corresponding live bacterial cell number to that at 0.5 hpi. The percentage survival of <italic>Y. pestis</italic> bacilli decreased drastically to about 25&#x02013;30% in both types of cells at 2 hpi at a MOI of 1. This percentage was sustained in RAW264.7 cells at a relatively steady level, dropping only 4% from 2 to 8 hpi; however, the bacteria inside the U937 cells were cleared much faster, as shown by the prominent decrease from 32 to 9% during this time period. At 32 hpi, no living 201 bacteria were detected in the U937 cells, whereas 10.6% of the bacteria were still alive in the RAW264.7 cells (<xref ref-type="fig" rid="F5">Figure 5</xref>). When the cells were infected with <italic>Y. pestis</italic> 201 at an MOI of 5, similar results were found, where the percentage survival of the 201 bacteria in the RAW264.7 cells was significantly higher than that in the U937 cells, indicating that human macrophages can clear the <italic>Y. pestis</italic> Microtus strain more efficiently than the murine macrophages.</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p><italic>Y. pestis</italic> strain 201 survival rates were significantly lower in U937 than in RAW264.7 cells. PMA primed U937 and RAW264.7 cells were infected with <italic>Y. pestis</italic> 201 strain at an MOI of 1 or 5, and the living bacteria inside the cells at 2, 4, 8, 20, and 32 hpi were counted by plating the cell lysates onto the agar plates. Experiments were performed in triplicates for three independent times and the similar results were obtained. The survival percentages of the bacteria, as based on a representative result, are shown in average and standard deviation.</p></caption>
<graphic xlink:href="fcimb-09-00111-g0005.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="materials and methods" id="s3">
<title>Materials and Methods</title>
<sec>
<title>Cell Cultures, Bacterial Strains and Infections</title>
<p>Peripheral lymphocytes were isolated from the whole blood collected from 8 healthy donors using Ficoll-Paque Plus (GE Healthcare, USA). The purified lymphocytes were maintained in RPMI-1640 medium supplemented with 10% fetal bovine serum (FBS) and 2 mmol/L of L-glutamine at 37&#x000B0;C in a 5% CO<sub>2</sub> incubator. <italic>Y. pestis</italic> 141 strain is a biovar Antiqua strain, highly virulent in mice and human. <italic>Y. pestis</italic> strain 201 belongs to the biovar Microtus and is highly virulent in mice but avirulent in humans. The glycerol-preserved strains were inoculated into 5 mL of brain heart infusion (BHI) medium and allowed to grow at 26&#x000B0;C for 24 h. The strains recovered were subjected to three consecutive passages and the third passage cultures were grown until they approached an optical density the (OD) <sub>600nm</sub> value equal to 1. Bacterial cultures were centrifuged and resuspened in RPMI-1640. The purified human peripheral lymphocytes were infected with the bacterial suspensions of 141 or 201 strains at an MOI of 10, and the infected cells were centrifuged briefly to promote the adhesion of the bacteria to the lymphocytes before incubation at 37&#x000B0;C in a 5% CO<sub>2</sub> incubator. Gentamycin at 100 &#x003BC;g/ml was added after 0.5 h of infection to kill the extracellular bacteria in order to inhibit the proliferation of the bacteria during infection. At the 0.5, 2, 4, and 8 hpi, the culture supernatants from the 201- or 141-infected lymphocytes were collected and centrifuged at 4.000 rpm for 5 min to remove the floating bacteria and cell debris, and the cleared supernatants were stored in small aliquots for the cytokine measurements. The infected lymphocytes were collected and subjected to total RNA isolation.</p>
</sec>
<sec>
<title>RNA Isolation, Sequencing and Data Analysis</title>
<p>Total RNAs were purified from the lymphocytes infected with strains 201 or 141 using a TRIzol reagent (Invitrogen, Carlsbad, CA) and the isolated RNAs were treated with RNAse free DNase I (Thermo Fisher Scientific, Waltham, MA). The RNA integrity number, rRNA ratio (28S/18S), and the total RNA concentration in the samples were determined according to the previous descriptions (Du et al., <xref ref-type="bibr" rid="B10">2014</xref>; Yang et al., <xref ref-type="bibr" rid="B42">2017</xref>). Sequencing libraries were prepared using the Illumina Truseq RNA sample preparation kit according to the manufacturer&#x00027;s protocol. Briefly, the first-strand cDNA was generated by First Strand Master Mix and SuperScript II reverse transcription using random primers and the second-strand cDNA was synthesized using DNA polymerase I and RNase H. The fragmented cDNA molecules were end-repaired, purified, and then ligated with PloyA. The sequencing was performed using Illumina HiSeq 2000 (Illumina Inc., USA). The original image data is converted into &#x0201C;raw reads&#x0201D; via base calling. To obtain clean reads of acceptable quality, raw data filtering and quality control were performed to remove the adaptors-containing reads, unknown bases amounting to more than 10%, or low quality bases. The Burrows-Wheeler alignment tool was used to map the clean reads to the human reference genome (NCBI36/hg18) (Li and Durbin, <xref ref-type="bibr" rid="B23">2009</xref>), and Bowtie was used to map to the reference genes (Langmead et al., <xref ref-type="bibr" rid="B21">2009</xref>). Genes and isoform expression levels were quantified by the RSEM software package. We used the FPKM method to calculate the gene expression levels (Mortazavi et al., <xref ref-type="bibr" rid="B27">2008</xref>). The FDR was computed by dividing the number of falsely discovered genes at a given p-value by the number of statistically significant differentially expressed genes comparing the sample to the control at the same p-value (Benjamini and Yekutieli, <xref ref-type="bibr" rid="B3">2005</xref>). The criteria used for differentially expressed genes (DEG) were FDR &#x02264; 0.001 and log2 (FPKM in the test sample/FPKM in the reference) &#x02265; 1. All the data discussed here have been deposited to GEO at NCBI with the accession number of <ext-link ext-link-type="DDBJ/EMBL/GenBank" xlink:href="GSE121084">GSE121084</ext-link>.</p>
</sec>
<sec>
<title>Quantitative Reverse Transcription PCR (qRT-PCR) Analysis</title>
<p>To confirm gene expression levels by qRT-PCR, RNA samples that were subjected to the RNA-sequencing were used as templets and the qRT-PCR analysis were performed based on SYBR Green I fluorescence using Roche Light Cycler 480. RNA samples from the uninfected, 201- or 141-infected lymphocytes collected at the 2, 4 and 8 hpi were used as templates with primer pairs to amplify the corresponding target genes (<xref ref-type="supplementary-material" rid="SM5">Supplementary Table 2</xref>). Correlations between the sequencing data and the qRT PCR results were calculated using linear regression methodology.</p>
</sec>
<sec>
<title>Cytokine Analysis</title>
<p>The cytokines present in the culture supernatants from human lymphocytes infected with 201 or 141 strains for 2, 4, and 8 h were detected using the BD&#x02122; Cytometric Bead Array (CBA) Human Inflammatory Cytokine Kit and Human Th1/Th2/Th17 Kit (BD Biosciences, San Jose, CA). The cytokines concentrations were measured by a Becton-Dickinson FACS Caliber flow cytometer. Cytokine levels were processed using Graphpad Prism 5.0, and the statistical significance of the differences in the cytokine levels between the different groups of samples were analyzed by two-way ANOVA analysis followed by Bonferroni post-tests.</p>
</sec>
<sec>
<title>Survival Capabilities of <italic>Y. pestis</italic> Strain 201 and 141 in U937 Cell and RAW264.7 Cells</title>
<p>U937 and RAW264.7 cells were maintained in RPMI 1640 medium containing 10% FBS and 2 mmol/L of L-glutamine at 37&#x000B0;C in a 5% CO<sub>2</sub> incubator. U937 cells were primed with PMA (100 ng/mL) for 48 hours before infection. U937 and RAW264.7 cells were seeded onto 24-well plates at a concentration of 4 &#x000D7; 10<sup>5</sup>/mL the day before infection. <italic>Y. pestis</italic> strains 201 and 141 were grown in BHI until they reached OD<sub>600nm</sub> &#x0003D; 1, and each were collected separately by centrifugation and resuspendend in RPMI 1640. The U937 cells or RAW264.7 cells were then infected with strains 201 or 141 at an MOI of 1 or 5, and gentamycin at 100 &#x003BC;g/ml was added to the cells to kill the extracellular bacteria after 0.5 h of infection. At 0.5, 2, 4, 8, 12, 20, 32 hpi, the culture medium from each well was decanted, the cells were thoroughly washed in phosphate-saline buffered saline (PBS), and the infected cells were lysed by addition of sterile H<sub>2</sub>O containing 0.1% Triton X-100 for 15 min at room temperature to release the engulfed bacteria. The living bacteria were counted by plating the diluted cell lysate onto to the agar plates in triplicate. This experiment was performed independently three times as biological triplicates and a representative result is shown as the mean &#x000B1; SD (<italic>n</italic> &#x0003D; 3).</p>
</sec>
<sec>
<title>Immunoblotting Detection of Proteins Involved in Lysosome Pathway in U937 Cell and RAW264.7 Cells</title>
<p>U937 cells were PMA-primed before they were infected with the <italic>Y. pestis</italic> strain as described above. U937 cells and RAW264.7 cells were maintained, seeded and infected with <italic>Y. pestis</italic> strains 201 and 141 at an MOI &#x0003D; 10, according to the method described in the survival capability assays. Gentamycin was added to the cultures to inhibit the over proliferation of the bacteria at 0.5 hpi. U937 and RAW264.7 cells were harvested at 2, 4, and 8 hpi, washed with ice-cold PBS, and lysed with lysis buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% TritonX-100, 1% sodium deoxycholate, 2 mM sodium pyrophosphate, 1 mM EDTA) supplemented with a protease inhibitor complete cocktail (Roche, Basel, Switzerland). Sodium dodecyl sulfate (SDS) loading buffer was added into the cell lysate, which was boiled and then separated by 12% SDS-polyacrylamide gel electrophoresis (SDS-PAGE), followed by transfer onto a polyvinylidene fluoride membrane (GE Healthcare, Piscataway, NJ, USA). Specific proteins were detected using antibodies against Actin, CTSZ, CTSD and SLC11A1(Santa Cruz Biotechnology, Dallas, TX).</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p><italic>Yersinia pestis</italic> has evolved from <italic>Y. pseudotuberculosis</italic>, a foodborne enteropathogenic pathogen responsible for self-limiting intestinal infections (Morelli et al., <xref ref-type="bibr" rid="B26">2010</xref>). Three pathogenic <italic>Yersinia</italic> bacteria shared a common 70-Kb virulence plasmid that encodes the type three secretion system (T3SS), which can deliver several <italic>Yersinia</italic> virulence effectors called <italic>Yersinia</italic> outer membrane proteins (Yops) into the eukaryotic cell cytosol to paralyze host defenses (Cornelis, <xref ref-type="bibr" rid="B7">2002</xref>). Acquiring pPCP1 and pMT1 plasmids has endowed <italic>Y. pestis</italic> with new virulent factors such as the F1 capsular antigen, the Pla plasminogen activator, and the murine toxin, all of which are critical for this bacterium to be a flea-transmitted lethal pathogen (Prentice and Rahalison, <xref ref-type="bibr" rid="B31">2007</xref>). Massive gene losses have also played very important roles in the evolution of <italic>Y. pestis</italic> (Chain et al., <xref ref-type="bibr" rid="B5">2004</xref>). Indeed, several newly acquired features contributing to the high pathogenicity and flea-bite transmissibility of <italic>Y. pestis</italic> have resulted from reductive evolution. For instance, the Inv and YadA adhesins which are needed for enteropathogenic yersiniae colonization the Peyer&#x00027;s patches and mesenteric lymph nodes, are both pseudogenes in <italic>Y. pestis</italic> (Marra and Isberg, <xref ref-type="bibr" rid="B25">1997</xref>; Parkhill et al., <xref ref-type="bibr" rid="B29">2001</xref>; Heise and Dersch, <xref ref-type="bibr" rid="B14">2006</xref>). Furthermore, with several biosynthesis gene for LPS being inactivated in <italic>Y. pestis</italic>, LPS in this bacterium lacks the O antigen and switches from a hexa-acylated to tetra-acylated form that is poorly recognized by TLR4 (Kawahara et al., <xref ref-type="bibr" rid="B18">2002</xref>; Rebeil et al., <xref ref-type="bibr" rid="B35">2004</xref>). <italic>Y. pestis</italic> Microtus strains are thought to lie on the evolutionarily oldest branch of the <italic>Y. pestis</italic>, which are capable of transmission via fleabites and are also highly virulent in mice but are unable to infect larger mammals such as rabbits, guinea pigs and humans (Fan et al., <xref ref-type="bibr" rid="B11">1995</xref>; Song et al., <xref ref-type="bibr" rid="B38">2004</xref>). Comparative genomic analysis of <italic>Y. pestis</italic> from distinct biovars has found little evidence in their different genome compositions to accounts for the host-specificity displayed by Microtus. Here, we sought to probe into this mystery in the context of the host response and further investigate the interactions between the Microtus strain and human or murine macrophages. Our results indicate that human peripheral lymphocytes respond differently to infections with the <italic>Y. pestis</italic> Microtus strain and the strain virulent for humans after their initial encounter, especially in several innate immunity pathways including the lysosome and TLR signaling pathways (<xref ref-type="fig" rid="F2">Figure 2</xref>). We assumed that the PAMPs that are present on the bacterial surface or the degraded small molecules arising from 201 and 141 bacteria are differentially recognized by human peripheral lymphocytes, leading to the distinct innate immune responses in these cells. Our additional <italic>in vitro</italic> study confirmed that the human macrophages were competent at clearing the biovar Microtus strains of <italic>Y. pestis</italic>, unlike the mouse macrophages where this bacterium was able to bacteria to survive for a much longer time (<xref ref-type="fig" rid="F5">Figure 5</xref>). This result is consistent with the transcriptomic results that gene expressions in the lysosome pathway were significantly enriched in the 201-infected lymphocytes and two functionally important proteins, CTSD and SLC11A1 that are involved in lysosome activation, showed enhanced expression. It has long been established that the initial interaction between the host macrophages and <italic>Y. pestis</italic> bacilli is critical to systemic infection progression, and our findings hint that human and murine macrophages exhibit distinct recognition or clearing abilities when infected with the Microtus strains. This finding is probably related to some uncharacterized features that differs between Microtus and the other biovars strains, or slight but very critical differences in some receptors between the human and mouse hosts. Further investigations are clearly needed in this area, especially for the discovery of the molecular mechanisms underlying the host-specific pathogenesis properties of the <italic>Y. pestis</italic> biovar Microtus strains.</p>
</sec>
<sec id="s5">
<title>Author Contributions</title>
<p>ZD, RY, and XZ designed and cooperated the study. QWZ, YX, HZ, and ZQ isolated peripheral lymphocytes and performed the cell infection experiments. RL, QZ, and QWZ performed the survival rates analysis of the <italic>Y. pestis</italic> strains and immunoblotting analysis. XX performed qRT-PCR analysis. ZD, YFY, and ZK analyzed the data. YS, YC, TW, and YY provided technical assistance. ZD and QWZ wrote the manuscript.</p>
<sec>
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack><p>This work was supported by the National Natural Science Foundation of China (grant no. 31430006,31470242). We thank Sandra Cheesman, Ph.D., from Liwen Bianji, Edanz Group China (<ext-link ext-link-type="uri" xlink:href="http://www.liwenbianji.cn/ac">www.liwenbianji.cn/ac</ext-link>), for editing the English text of a draft of this manuscript.</p>
</ack>
<sec sec-type="supplementary-material" id="s6">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2019.00111/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2019.00111/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Image_1.JPEG" id="SM1" mimetype="image/jpeg" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Figure 1</label>
<caption><p>Correlations between the expression levels of 23 genes measured by RNA-seq and qRT-PCR were analyzed using the linear regression method.</p></caption>
</supplementary-material>
<supplementary-material xlink:href="Image_2.JPEG" id="SM2" mimetype="image/jpeg" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Figure 2</label>
<caption><p>Several important molecules in the TLR signaling pathway were differentially expressed in the 201- and 141-infected human lymphocytes. Changes in the expression levels of CD14, IRF5, TLR8, and TICAM2 in 201- and 141-infected lymphocytes were plotted against the time point from infection initiation according to the RNA-seq analysis results <bold>(A)</bold>. Expression changes for the same group of genes were plotted according to the qRT-PCR results <bold>(B)</bold>.</p></caption>
</supplementary-material>
<supplementary-material xlink:href="Image_3.JPEG" id="SM3" mimetype="image/jpeg" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Figure 3</label>
<caption><p>Several important molecules in the lysosome pathway were differentially expressed in the 201- and 141-infected human lymphocytes. Changes in the expression levels of ATP6V0A1, CTSD, CTSK and SLC11A1 in the 201- and 141-infected lymphocytes were plotted against the time point from infection initation according to the RNA-seq analysis results <bold>(A)</bold>. Expression changes for the same group of genes were plotted according to the qRT-PCR results <bold>(B)</bold>.</p></caption>
</supplementary-material>
<supplementary-material xlink:href="Table_1.XLSX" id="SM4" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Table 1</label>
<caption><p>Primers used for qRT-PCR.</p></caption>
</supplementary-material>
<supplementary-material xlink:href="Table_2.XLSX" id="SM5" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet" xmlns:xlink="http://www.w3.org/1999/xlink">
<label>Supplementary Table 2</label>
<caption><p>Correlation coefficients between RNA-seq analysis and q-RT PCR results were analyzed using the samples from the lymphocytes infected with strain 201 and the normal cell control.</p></caption>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Achtman</surname> <given-names>M.</given-names></name> <name><surname>Morelli</surname> <given-names>G.</given-names></name> <name><surname>Zhu</surname> <given-names>P.</given-names></name> <name><surname>Wirth</surname> <given-names>T.</given-names></name> <name><surname>Diehl</surname> <given-names>I.</given-names></name> <name><surname>Kusecek</surname> <given-names>B.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Microevolution and history of the plague bacillus, <italic>Yersinia pestis</italic></article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>101</volume>, <fpage>17837</fpage>&#x02013;<lpage>17842</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0408026101</pub-id><pub-id pub-id-type="pmid">15598742</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Achtman</surname> <given-names>M.</given-names></name> <name><surname>Zurth</surname> <given-names>K.</given-names></name> <name><surname>Morelli</surname> <given-names>G.</given-names></name> <name><surname>Torrea</surname> <given-names>G.</given-names></name> <name><surname>Guiyoule</surname> <given-names>A.</given-names></name> <name><surname>Carniel</surname> <given-names>E.</given-names></name></person-group> (<year>1999</year>). <article-title><italic>Yersinia pestis</italic>, the cause of plague, is a recently emerged clone of <italic>Yersinia pseudotuberculosis</italic></article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>96</volume>, <fpage>14043</fpage>&#x02013;<lpage>14048</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.96.24.14043</pub-id><pub-id pub-id-type="pmid">10570195</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Benjamini</surname> <given-names>Y.</given-names></name> <name><surname>Yekutieli</surname> <given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>Quantitative trait Loci analysis using the false discovery rate</article-title>. <source>Genetics</source> <volume>171</volume>, <fpage>783</fpage>&#x02013;<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1534/genetics.104.036699</pub-id><pub-id pub-id-type="pmid">15956674</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname> <given-names>T.</given-names></name></person-group> (<year>2009</year>). <article-title>Plague into the 21st century</article-title>. <source>Clin. Infect. Dis.</source> <volume>49</volume>, <fpage>736</fpage>&#x02013;<lpage>742</lpage>. <pub-id pub-id-type="doi">10.1086/604718</pub-id><pub-id pub-id-type="pmid">19606935</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chain</surname> <given-names>P. S.</given-names></name> <name><surname>Carniel</surname> <given-names>E.</given-names></name> <name><surname>Larimer</surname> <given-names>F. W.</given-names></name> <name><surname>Lamerdin</surname> <given-names>J.</given-names></name> <name><surname>Stoutland</surname> <given-names>P. O.</given-names></name> <name><surname>Regala</surname> <given-names>W. M.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Insights into the evolution of <italic>Yersinia pestis</italic> through whole-genome comparison with <italic>Yersinia pseudotuberculosis</italic></article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>101</volume>, <fpage>13826</fpage>&#x02013;<lpage>13831</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0404012101</pub-id><pub-id pub-id-type="pmid">15358858</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Connor</surname> <given-names>M. G.</given-names></name> <name><surname>Pulsifer</surname> <given-names>A. R.</given-names></name> <name><surname>Price</surname> <given-names>C. T.</given-names></name> <name><surname>Abu Kwaik</surname> <given-names>Y.</given-names></name> <name><surname>Lawrenz</surname> <given-names>M. B.</given-names></name></person-group> (<year>2015</year>). <article-title><italic>Yersinia pestis</italic> requires host Rab1b for survival in macrophages</article-title>. <source>PLoS Pathog</source> <volume>11</volume>:<fpage>e1005241</fpage>. <pub-id pub-id-type="doi">10.1371/journal.ppat.1005241</pub-id><pub-id pub-id-type="pmid">26495854</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cornelis</surname> <given-names>G. R.</given-names></name></person-group> (<year>2002</year>). <article-title>Yersinia type III secretion: send in the effectors</article-title>. <source>J. Cell Biol.</source> <volume>158</volume>, <fpage>401</fpage>&#x02013;<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200205077</pub-id><pub-id pub-id-type="pmid">12163464</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>del Cerro-Vadillo</surname> <given-names>E.</given-names></name> <name><surname>Madrazo-Toca</surname> <given-names>F.</given-names></name> <name><surname>Carrasco-Mar&#x000ED;n</surname> <given-names>E.</given-names></name> <name><surname>Fernandez-Prieto</surname> <given-names>L.</given-names></name> <name><surname>Beck</surname> <given-names>C.</given-names></name> <name><surname>Leyva-Cobi&#x000E1;n</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2006</year>). <article-title>Cutting edge: a novel nonoxidative phagosomal mechanism exerted by cathepsin-D controls <italic>Listeria monocytogenes</italic> intracellular growth</article-title>. <source>J. Immunol.</source> <volume>176</volume>, <fpage>1321</fpage>&#x02013;<lpage>1325</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.176.3.1321</pub-id><pub-id pub-id-type="pmid">16424157</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deng</surname> <given-names>W.</given-names></name> <name><surname>Burland</surname> <given-names>V.</given-names></name> <name><surname>Plunkett</surname> <given-names>G.</given-names></name> <name><surname>Boutin</surname> <given-names>A.</given-names></name> <name><surname>Mayhew</surname> <given-names>G. F.</given-names></name> <name><surname>Liss</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2002</year>). <article-title>Genome sequence of <italic>Yersinia pestis</italic> KIM</article-title>. <source>J. Bacteriol.</source> <volume>184</volume>, <fpage>4601</fpage>&#x02013;<lpage>4611</lpage>. <pub-id pub-id-type="doi">10.1128/JB.184.16.4601-4611.2002</pub-id><pub-id pub-id-type="pmid">12142430</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Du</surname> <given-names>Z.</given-names></name> <name><surname>Yang</surname> <given-names>H.</given-names></name> <name><surname>Tan</surname> <given-names>Y.</given-names></name> <name><surname>Tian</surname> <given-names>G.</given-names></name> <name><surname>Zhang</surname> <given-names>Q.</given-names></name> <name><surname>Cui</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Transcriptomic response to <italic>Yersinia pestis</italic>: RIG-I like receptor signaling response is detrimental to the host against plague</article-title>. <source>J. Genet. Genomics</source> <volume>41</volume>, <fpage>379</fpage>&#x02013;<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1016/j.jgg.2014.05.006</pub-id><pub-id pub-id-type="pmid">25064677</pub-id></citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fan</surname> <given-names>Z.</given-names></name> <name><surname>Luo</surname> <given-names>Y</given-names></name> <name><surname>Wang</surname> <given-names>S.</given-names></name> <name><surname>Jin</surname> <given-names>L.</given-names></name> <name><surname>Zhou</surname> <given-names>X.</given-names></name> <name><surname>Liu</surname> <given-names>J.</given-names></name> <etal/></person-group>. (<year>1995</year>). <article-title>Microtus brandti plague in the Xilin Gol Grassland was inoffensive to human</article-title>. <source>Chin. J. Control Endemic Dis.</source> <volume>10</volume>, <fpage>56</fpage>&#x02013;<lpage>57</lpage>.</citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Govoni</surname> <given-names>G.</given-names></name> <name><surname>Canonne-Hergaux</surname> <given-names>F.</given-names></name> <name><surname>Pfeifer</surname> <given-names>C. G.</given-names></name> <name><surname>Marcus</surname> <given-names>S. L.</given-names></name> <name><surname>Mills</surname> <given-names>S. D.</given-names></name> <name><surname>Hackam</surname> <given-names>D. J.</given-names></name> <etal/></person-group>. (<year>1999</year>). <article-title>Functional expression of Nramp1 <italic>in vitro</italic> in the murine macrophage line RAW264.7</article-title>. <source>Infect. Immun.</source> <volume>67</volume>, <fpage>2225</fpage>&#x02013;<lpage>2232</lpage>. <pub-id pub-id-type="pmid">10225878</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Grabenstein</surname> <given-names>J. P.</given-names></name> <name><surname>Fukuto</surname> <given-names>H. S.</given-names></name> <name><surname>Palmer</surname> <given-names>L. E.</given-names></name> <name><surname>Bliska</surname> <given-names>J. B.</given-names></name></person-group> (<year>2006</year>). <article-title>Characterization of phagosome trafficking and identification of PhoP-regulated genes important for survival of <italic>Yersinia pestis</italic> in macrophages</article-title>. <source>Infect. Immun.</source> <volume>74</volume>, <fpage>3727</fpage>&#x02013;<lpage>3741</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00255-06</pub-id><pub-id pub-id-type="pmid">16790745</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Heise</surname> <given-names>T.</given-names></name> <name><surname>Dersch</surname> <given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Identification of a domain in <italic>Yersinia</italic> virulence factor YadA that is crucial for extracellular matrix-specific cell adhesion and uptake</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>103</volume>, <fpage>3375</fpage>&#x02013;<lpage>3380</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0507749103</pub-id><pub-id pub-id-type="pmid">16488979</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang da</surname> <given-names>W.</given-names></name> <name><surname>Sherman</surname> <given-names>B. T.</given-names></name> <name><surname>Lempicki</surname> <given-names>R. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title>. <source>Nat. Protoc.</source> <volume>4</volume>, <fpage>44</fpage>&#x02013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id><pub-id pub-id-type="pmid">19131956</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Inglesby</surname> <given-names>T. V.</given-names></name> <name><surname>Dennis</surname> <given-names>D. T.</given-names></name> <name><surname>Henderson</surname> <given-names>D. A.</given-names></name> <name><surname>Bartlett</surname> <given-names>J. G.</given-names></name> <name><surname>Ascher</surname> <given-names>M. S.</given-names></name> <name><surname>Eitzen</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2000</year>). <article-title>Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense</article-title>. <source>JAMA</source> <volume>283</volume>, <fpage>2281</fpage>&#x02013;<lpage>2290</lpage>. <pub-id pub-id-type="doi">10.1001/jama.283.17.2281</pub-id><pub-id pub-id-type="pmid">10807389</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishihara</surname> <given-names>S.</given-names></name> <name><surname>Rumi</surname> <given-names>M. A.</given-names></name> <name><surname>Kadowaki</surname> <given-names>Y.</given-names></name> <name><surname>Ortega-Cava</surname> <given-names>C. F.</given-names></name> <name><surname>Yuki</surname> <given-names>T.</given-names></name> <name><surname>Yoshino</surname> <given-names>N.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Essential role of MD-2 in TLR4-dependent signaling during <italic>Helicobacter pylori</italic>-associated gastritis</article-title>. <source>J. Immunol.</source> <volume>173</volume>, <fpage>1406</fpage>&#x02013;<lpage>1416</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.173.2.1406</pub-id><pub-id pub-id-type="pmid">15240737</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawahara</surname> <given-names>K.</given-names></name> <name><surname>Tsukano</surname> <given-names>H.</given-names></name> <name><surname>Watanabe</surname> <given-names>H.</given-names></name> <name><surname>Lindner</surname> <given-names>B.</given-names></name> <name><surname>Matsuura</surname> <given-names>M.</given-names></name></person-group> (<year>2002</year>). <article-title>Modification of the structure and activity of lipid A in <italic>Yersinia pestis</italic> lipopolysaccharide by growth temperature</article-title>. <source>Infect. Immun.</source> <volume>70</volume>, <fpage>4092</fpage>&#x02013;<lpage>4098</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.70.8.4092-4098.2002</pub-id><pub-id pub-id-type="pmid">12117916</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koren</surname> <given-names>H. S.</given-names></name> <name><surname>Anderson</surname> <given-names>S. J.</given-names></name> <name><surname>Larrick</surname> <given-names>J. W.</given-names></name></person-group> (<year>1979</year>). <article-title><italic>In vitro</italic> activation of a human macrophage-like cell line</article-title>. <source>Nature</source> <volume>279</volume>, <fpage>328</fpage>&#x02013;<lpage>331</lpage>. <pub-id pub-id-type="doi">10.1038/279328a0</pub-id><pub-id pub-id-type="pmid">450085</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Krishnan</surname> <given-names>J.</given-names></name> <name><surname>Selvarajoo</surname> <given-names>K.</given-names></name> <name><surname>Tsuchiya</surname> <given-names>M.</given-names></name> <name><surname>Lee</surname> <given-names>G.</given-names></name> <name><surname>Choi</surname> <given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>Toll-like receptor signal transduction</article-title>. <source>Exp. Mol. Med.</source> <volume>39</volume>, <fpage>421</fpage>&#x02013;<lpage>438</lpage>. <pub-id pub-id-type="doi">10.1038/emm.2007.47</pub-id><pub-id pub-id-type="pmid">17934330</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Langmead</surname> <given-names>B.</given-names></name> <name><surname>Trapnell</surname> <given-names>C.</given-names></name> <name><surname>Pop</surname> <given-names>M.</given-names></name> <name><surname>Salzberg</surname> <given-names>S. L.</given-names></name></person-group> (<year>2009</year>). <article-title>Ultrafast and memory-efficient alignment of short DNA sequences to the human genome</article-title>. <source>Genome Biol.</source> <volume>10</volume>:<fpage>R25</fpage>. <pub-id pub-id-type="doi">10.1186/gb-2009-10-3-r25</pub-id><pub-id pub-id-type="pmid">19261174</pub-id></citation></ref>
<ref id="B22">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Leeuwenberg</surname> <given-names>J. F.</given-names></name> <name><surname>Dentener</surname> <given-names>M. A.</given-names></name> <name><surname>Buurman</surname> <given-names>W. A.</given-names></name></person-group> (<year>1994</year>). <article-title>Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein</article-title>. <source>J. Immunol.</source> <volume>152</volume>, <fpage>5070</fpage>&#x02013;<lpage>5076</lpage>. <pub-id pub-id-type="pmid">7513728</pub-id></citation></ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H.</given-names></name> <name><surname>Durbin</surname> <given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Fast and accurate short read alignment with Burrows-Wheeler transform</article-title>. <source>Bioinformatics</source> <volume>25</volume>, <fpage>1754</fpage>&#x02013;<lpage>1760</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id><pub-id pub-id-type="pmid">19451168</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>B.</given-names></name> <name><surname>Fang</surname> <given-names>M.</given-names></name> <name><surname>Hu</surname> <given-names>Y.</given-names></name> <name><surname>Huang</surname> <given-names>B.</given-names></name> <name><surname>Li</surname> <given-names>N.</given-names></name> <name><surname>Chang</surname> <given-names>C.</given-names></name> <etal/></person-group>. (<year>2014</year>). <article-title>Hepatitis B virus X protein inhibits autophagic degradation by impairing lysosomal maturation</article-title>. <source>Autophagy</source> <volume>10</volume>, <fpage>416</fpage>&#x02013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.4161/auto.27286</pub-id><pub-id pub-id-type="pmid">24401568</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marra</surname> <given-names>A.</given-names></name> <name><surname>Isberg</surname> <given-names>R.</given-names></name></person-group> (<year>1997</year>). <article-title>Invasin-dependent and invasin-independent pathways for translocation of <italic>Yersinia pseudotuberculosis</italic> across the Peyer&#x00027;s patch intestinal epithelium</article-title>. <source>Infect. Immun.</source> <volume>65</volume>, <fpage>3412</fpage>&#x02013;<lpage>3421</lpage>. <pub-id pub-id-type="pmid">9234806</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morelli</surname> <given-names>G.</given-names></name> <name><surname>Song</surname> <given-names>Y.</given-names></name> <name><surname>Mazzoni</surname> <given-names>C. J.</given-names></name> <name><surname>Eppinger</surname> <given-names>M.</given-names></name> <name><surname>Roumagnac</surname> <given-names>P.</given-names></name> <name><surname>Wagner</surname> <given-names>D. M.</given-names></name> <etal/></person-group>. (<year>2010</year>). <article-title><italic>Yersinia pestis</italic> genome sequencing identifies patterns of global phylogenetic diversity</article-title>. <source>Nat. Genet.</source> <volume>42</volume>, <fpage>1140</fpage>&#x02013;<lpage>1143</lpage>. <pub-id pub-id-type="doi">10.1038/ng.705</pub-id><pub-id pub-id-type="pmid">21037571</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mortazavi</surname> <given-names>A.</given-names></name> <name><surname>Williams</surname> <given-names>B. A.</given-names></name> <name><surname>McCue</surname> <given-names>K.</given-names></name> <name><surname>Schaeffer</surname> <given-names>L.</given-names></name> <name><surname>Wold</surname> <given-names>B.</given-names></name></person-group> (<year>2008</year>). <article-title>Mapping and quantifying mammalian transcriptomes by RNA-Seq</article-title>. <source>Nat. Methods</source> <volume>5</volume>, <fpage>621</fpage>&#x02013;<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.1226</pub-id><pub-id pub-id-type="pmid">18516045</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parent</surname> <given-names>M. A.</given-names></name> <name><surname>Wilhelm</surname> <given-names>L. B.</given-names></name> <name><surname>Kummer</surname> <given-names>L. W.</given-names></name> <name><surname>Szaba</surname> <given-names>F. M.</given-names></name> <name><surname>Mullarky</surname> <given-names>I. K.</given-names></name> <name><surname>Smiley</surname> <given-names>S. T.</given-names></name></person-group> (<year>2006</year>). <article-title>Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary <italic>Yersinia pestis</italic> infection</article-title>. <source>Infect. Immun.</source> <volume>74</volume>, <fpage>3381</fpage>&#x02013;<lpage>3386</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00185-06</pub-id><pub-id pub-id-type="pmid">16714568</pub-id></citation></ref>
<ref id="B29">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parkhill</surname> <given-names>J.</given-names></name> <name><surname>Wren</surname> <given-names>B. W.</given-names></name> <name><surname>Thomson</surname> <given-names>N. R.</given-names></name> <name><surname>Titball</surname> <given-names>R. W.</given-names></name> <name><surname>Holden</surname> <given-names>M. T.</given-names></name> <name><surname>Prentice</surname> <given-names>M. B.</given-names></name> <etal/></person-group>. (<year>2001</year>). <article-title>Genome sequence of <italic>Yersinia pestis</italic>, the causative agent of plague</article-title>. <source>Nature</source> <volume>413</volume>, <fpage>523</fpage>&#x02013;<lpage>527</lpage>. <pub-id pub-id-type="doi">10.1038/35097083</pub-id><pub-id pub-id-type="pmid">11586360</pub-id></citation></ref>
<ref id="B30">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname> <given-names>R. D.</given-names></name> <name><surname>Fetherston</surname> <given-names>J. D.</given-names></name></person-group> (<year>1997</year>). <article-title><italic>Yersinia pestis</italic>&#x02013;etiologic agent of plague</article-title>. <source>Clin. Microbiol. Rev.</source> <volume>10</volume>, <fpage>35</fpage>&#x02013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.10.1.35</pub-id></citation></ref>
<ref id="B31">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prentice</surname> <given-names>M. B.</given-names></name> <name><surname>Rahalison</surname> <given-names>L.</given-names></name></person-group> (<year>2007</year>). <source>Plague. Lancet</source> <volume>369</volume>, <fpage>1196</fpage>&#x02013;<lpage>1207</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(07)60566-2</pub-id></citation></ref>
<ref id="B32">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pujol</surname> <given-names>C.</given-names></name> <name><surname>Grabenstein</surname> <given-names>J. P.</given-names></name> <name><surname>Perry</surname> <given-names>R. D.</given-names></name> <name><surname>Bliska</surname> <given-names>J. B.</given-names></name></person-group> (<year>2005</year>). <article-title>Replication of <italic>Yersinia pestis</italic> in interferon gamma-activated macrophages requires ripA, a gene encoded in the pigmentation locus</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source> <volume>102</volume>, <fpage>12909</fpage>&#x02013;<lpage>12914</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0502849102</pub-id><pub-id pub-id-type="pmid">16120681</pub-id></citation></ref>
<ref id="B33">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pujol</surname> <given-names>C.</given-names></name> <name><surname>Klein</surname> <given-names>K. A.</given-names></name> <name><surname>Romanov</surname> <given-names>G. A.</given-names></name> <name><surname>Palmer</surname> <given-names>L. E.</given-names></name> <name><surname>Cirota</surname> <given-names>C.</given-names></name> <name><surname>Zhao</surname> <given-names>Z.</given-names></name> <etal/></person-group>. (<year>2009</year>). <article-title><italic>Yersinia pestis</italic> can reside in autophagosomes and avoid xenophagy in murine macrophages by preventing vacuole acidification</article-title>. <source>Infect. Immun.</source> <volume>77</volume>, <fpage>2251</fpage>&#x02013;<lpage>2261</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00068-09</pub-id><pub-id pub-id-type="pmid">19289509</pub-id></citation></ref>
<ref id="B34">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ratner</surname> <given-names>D.</given-names></name> <name><surname>Orning</surname> <given-names>M. P.</given-names></name> <name><surname>Starheim</surname> <given-names>K. K.</given-names></name> <name><surname>Marty-Roix</surname> <given-names>R.</given-names></name> <name><surname>Proulx</surname> <given-names>M. K.</given-names></name> <name><surname>Goguen</surname> <given-names>J. D.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Manipulation of Interleukin-1beta and Interleukin-18 production by <italic>Yersinia pestis</italic> effectors YopJ and YopM and redundant impact on virulence</article-title>. <source>J. Biol. Chem.</source> <volume>291</volume>, <fpage>9894</fpage>&#x02013;<lpage>9905</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.697698</pub-id></citation></ref>
<ref id="B35">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rebeil</surname> <given-names>R.</given-names></name> <name><surname>Ernst</surname> <given-names>R. K.</given-names></name> <name><surname>Gowen</surname> <given-names>B. B.</given-names></name> <name><surname>Miller</surname> <given-names>S. I.</given-names></name> <name><surname>Hinnebusch</surname> <given-names>B. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Variation in lipid A structure in the pathogenic <italic>yersiniae</italic></article-title>. <source>Mol. Microbiol.</source> <volume>52</volume>, <fpage>1363</fpage>&#x02013;<lpage>1373</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04059.x</pub-id><pub-id pub-id-type="pmid">15165239</pub-id></citation></ref>
<ref id="B36">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sarvestani</surname> <given-names>S. T.</given-names></name> <name><surname>Williams</surname> <given-names>B. R.</given-names></name> <name><surname>Gantier</surname> <given-names>M. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Human Toll-like receptor 8 can be cool too: implications for foreign RNA sensing</article-title>. <source>J. Interferon Cytokine Res.</source> <volume>32</volume>, <fpage>350</fpage>&#x02013;<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1089/jir.2012.0014</pub-id><pub-id pub-id-type="pmid">22817608</pub-id></citation></ref>
<ref id="B37">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saw</surname> <given-names>N. M.</given-names></name> <name><surname>Kang</surname> <given-names>S. Y.</given-names></name> <name><surname>Parsaud</surname> <given-names>L.</given-names></name> <name><surname>Han</surname> <given-names>G. A.</given-names></name> <name><surname>Jiang</surname> <given-names>T.</given-names></name> <name><surname>Grzegorczyk</surname> <given-names>K.</given-names></name> <etal/></person-group>. (<year>2011</year>). <article-title>Vacuolar H<sup>(&#x0002B;)</sup>-ATPase subunits Voa1 and Voa2 cooperatively regulate secretory vesicle acidification, transmitter uptake, and storage</article-title>. <source>Mol. Biol. Cell.</source> <volume>22</volume>, <fpage>3394</fpage>&#x02013;<lpage>3409</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.e11-02-0155</pub-id><pub-id pub-id-type="pmid">21795392</pub-id></citation></ref>
<ref id="B38">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>Y.</given-names></name> <name><surname>Tong</surname> <given-names>Z.</given-names></name> <name><surname>Wang</surname> <given-names>J.</given-names></name> <name><surname>Wang</surname> <given-names>L.</given-names></name> <name><surname>Guo</surname> <given-names>Z.</given-names></name> <name><surname>Han</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Complete genome sequence of <italic>Yersinia pestis</italic> strain 91001, an isolate avirulent to humans</article-title>. <source>DNA Res.</source> <volume>11</volume>, <fpage>179</fpage>&#x02013;<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1093/dnares/11.3.179</pub-id><pub-id pub-id-type="pmid">15368893</pub-id></citation></ref>
<ref id="B39">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takeuchi</surname> <given-names>O.</given-names></name> <name><surname>Akira</surname> <given-names>S.</given-names></name></person-group> (<year>2010</year>). <article-title>Pattern recognition receptors and inflammation</article-title>. <source>Cell</source> <volume>140</volume>, <fpage>805</fpage>&#x02013;<lpage>820</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2010.01.022</pub-id><pub-id pub-id-type="pmid">20303872</pub-id></citation></ref>
<ref id="B40">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tranchemontagne</surname> <given-names>Z. R.</given-names></name> <name><surname>Camire</surname> <given-names>R. B.</given-names></name> <name><surname>O&#x00027;Donnell</surname> <given-names>V. J.</given-names></name> <name><surname>Baugh</surname> <given-names>J.</given-names></name> <name><surname>Burkholder</surname> <given-names>K. M.</given-names></name></person-group> (<year>2016</year>). <article-title><italic>Staphylococcus aureus</italic> strain USA300 perturbs acquisition of lysosomal enzymes and requires phagosomal acidification for survival inside macrophages</article-title>. <source>Infect. Immun.</source> <volume>84</volume>, <fpage>241</fpage>&#x02013;<lpage>253</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00704-15</pub-id><pub-id pub-id-type="pmid">26502911</pub-id></citation></ref>
<ref id="B41">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname> <given-names>J. K.</given-names></name> <name><surname>Xu</surname> <given-names>J. L.</given-names></name> <name><surname>Tapping</surname> <given-names>R. I.</given-names></name></person-group> (<year>2009</year>). <article-title>Substrains of 129 mice are resistant to <italic>Yersinia pestis</italic> KIM5: implications for interleukin-10-deficient mice</article-title>. <source>Infect. Immun.</source> <volume>77</volume>, <fpage>367</fpage>&#x02013;<lpage>373</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.01057-08</pub-id><pub-id pub-id-type="pmid">18955473</pub-id></citation></ref>
<ref id="B42">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>H.</given-names></name> <name><surname>Wang</surname> <given-names>T.</given-names></name> <name><surname>Tian</surname> <given-names>G.</given-names></name> <name><surname>Zhang</surname> <given-names>Q.</given-names></name> <name><surname>Wu</surname> <given-names>X.</given-names></name> <name><surname>Xin</surname> <given-names>Y.</given-names></name> <etal/></person-group>. (<year>2017</year>). <article-title>Host transcriptomic responses to pneumonic plague reveal that <italic>Yersinia pestis</italic> inhibits both the initial adaptive and innate immune responses in mice</article-title>. <source>Int. J. Med. Microbiol.</source> <volume>307</volume>, <fpage>64</fpage>&#x02013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijmm.2016.11.002</pub-id><pub-id pub-id-type="pmid">27876297</pub-id></citation></ref>
<ref id="B43">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>D.</given-names></name> <name><surname>Tong</surname> <given-names>Z.</given-names></name> <name><surname>Song</surname> <given-names>Y.</given-names></name> <name><surname>Han</surname> <given-names>Y.</given-names></name> <name><surname>Pei</surname> <given-names>D.</given-names></name> <name><surname>Pang</surname> <given-names>X.</given-names></name> <etal/></person-group>. (<year>2004</year>). <article-title>Genetics of metabolic variations between <italic>Yersinia pestis</italic> biovars and the proposal of a new biovar, microtus</article-title>. <source>J. Bacteriol.</source> <volume>186</volume>, <fpage>5147</fpage>&#x02013;<lpage>5152</lpage>. <pub-id pub-id-type="doi">10.1128/JB.186.15.5147-5152.2004</pub-id><pub-id pub-id-type="pmid">15262951</pub-id></citation></ref>
<ref id="B44">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>L.</given-names></name> <name><surname>Ying</surname> <given-names>W.</given-names></name> <name><surname>Han</surname> <given-names>Y.</given-names></name> <name><surname>Chen</surname> <given-names>M.</given-names></name> <name><surname>Yan</surname> <given-names>Y.</given-names></name> <name><surname>Li</surname> <given-names>L.</given-names></name> <etal/></person-group>. (<year>2012</year>). <article-title>A proteome reference map and virulence factors analysis of <italic>Yersinia pestis</italic> 91001</article-title>. <source>J. Proteomics</source> <volume>75</volume>, <fpage>894</fpage>&#x02013;<lpage>907</lpage>. <pub-id pub-id-type="doi">10.1016/j.jprot.2011.10.004</pub-id><pub-id pub-id-type="pmid">22040741</pub-id></citation></ref>
</ref-list>
</back>
</article>